Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
Science China Life Sciences · 2025-11 · 68 (11) · 3281-3302
DOI: 10.1007/s11427-025-2979-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science China Life Sciences, online erschienen am 25.07.2025. Verfasst von Siying Lyu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Hauptthemen laut MEDLINE: Neoplasms, Signal Transduction. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 289 Literaturangaben. Gefördert von: NCRR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Metabolic reprogramming is a hallmark of cancer, playing a critical role in tumorigenesis by supporting cancer cell survival, proliferation, metastasis, and immune evasion. Oncogenic signaling pathways regulate key metabolic processes by orchestrating gene expression and enhancing metabolic enzyme activity, ensuring cancer cells meet their bioenergetic and biosynthetic demands. Here, we highlight the roles of major oncogenic metabolic signaling pathways, including phosphoinositide 3-kinase (PI3K)/AKT, Myc, p53, and hypoxia-inducible factor (HIF), in driving metabolic rewiring. We provide a conceptual framework to understand why metabolic reprogramming occurs in tumor cells, how metabolic alterations contribute to tumorigenesis, metastasis, and immune evasion, and the therapeutic implications of targeting these metabolic vulnerabilities in cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Qing.Zhang@UTSouthwestern.edu.
- Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Qing.Zhang@UTSouthwestern.edu.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA. Chengheng.Liao@UTSouthwestern.edu.
Förderung
- NCRR NIH HHS
- NCI NIH HHS
Zitieren
APA
Lyu, S., Gildor, N., Zhang, Q., & Liao, C. (2025). Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics. Science China Life Sciences, 68(11), 3281-3302. https://doi.org/10.1007/s11427-025-2979-3
Vancouver
Lyu S, Gildor N, Zhang Q, Liao C. Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics. Science China Life Sciences. 2025;68(11):3281-3302. doi:10.1007/s11427-025-2979-3
BibTeX
@article{Lyu2025,
author = {Lyu, Siying and Gildor, Nina and Zhang, Qing and Liao, Chengheng},
title = {Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics},
journal = {Science China Life Sciences},
year = {2025},
volume = {68},
number = {11},
pages = {3281--3302},
doi = {10.1007/s11427-025-2979-3}
}
EUVIMED